Search clinical trials for: 38-hour duration between ovulation triggering and oocyte pick-up procedure
Total 4 results
-
Koç UniversityTurkish Society of Reproductive MedicineRecruiting
-
Cairo UniversityRecruiting
-
Cairo UniversityUnknown
Sponsors and Collaborators
- Alfred Hospital Intensive Care Unit Australia
- Delosis Limited
- InfraScan, Inc.
- The First Affiliated Hospital of Air Force Medicial University
- IDRI Corporation
- Deutsche Arthrose-Hilfe
- Jiajie Chen
- Jikei University School of Medicine
- Centre Hospitalier de Bastia
- Faculdade de Medicina da Universidade do Porto (FMUP)
- RINO ZUID
- Shamir Optical Industry Ltd
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- Prof. Jürgen Kuschyk, M.D
- Donna Hammond, PhD
- Research Unit of General Practice, Odense
- Canadian Hemophilia Society
- Institute of Antibiotics, Huashan Hospital, Fudan University
- University of Natural Resources and Life Sciences, Vienna, Austria
- Stefania Basili
- View Full List
Medical Conditions
- Inotropic Agents
- Diarrheal Disease, Infectious
- Gait, Spastic
- Chronic Pruritus of Unknown Origin
- Pulmonary Arteriovenous Malformations
- Stage IVA Laryngeal Verrucous Carcinoma
- The Coagulolytic Balance
- Homocystinuria Due to Cystathionine Beta-Synthase Deficiency
- Febrile
- BK Viremia
- Pathological Fracture, Right Femur
- Respiratory Distress Syndrome, Pediatric
- Pharyngitis, Infective
- Sickle Cell Ulcer
- Trauma Dental
- Pancreatobiliary Disease
- Therapy-Related MDS
- CaIMR
- Pneumonectomy; Status
- Cancer Survivor With History of Anthracycline Chemotherapy
- View Full List
Drug Interventions
- Radioligand (11C)AZD2184
- Chlorcyclizine HCl
- Rosuvastatin calcium tablets
- LIS 18 U
- Moxifloxacin
- Propranolol Hydrochloride Extended Release Capsules 160 mg
- Nanoliposomal Irinotecan
- Atorvastatin, 10mg, 20mg, 40mg
- Epoetin beta (NeoRecormon®)
- Gemcitabine (mg/m²)
- Hypertonic saline
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
- Arm 1 - GEH120714 (18F) Injection
- Sorafenib and OSI-906
- Prucalopride
- HLX23
- Domperidone
- INCB7839
- JR-141
- PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Croatia
- Contract Research Organizations in Georgia
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Poland
- Contract Research Organizations in Senegal
- Contract Research Organizations in Singapore
- Contract Research Organizations in United States
- Contract Research Organizations in Venezuela
- Contract Research Organizations in Zambia
- CRO list by country